Fractional First

Want to see more candidates like this?

This is an anonymous profile. Contact Fractional First to view full profiles and discover more world-class fractional executives.

View Full Profiles

Strategic Capital Allocation Expert

Capital Allocation Strategist & Risk Analyst

Singapore

Description

This leader is a seasoned strategist with a Ph.D. in Human/Medical Genetics, specializing in capital allocation, risk judgment, and long-term value creation. With extensive experience in public-sector science and innovation, this executive excels in navigating complex problems and translating intricate concepts into actionable strategies. Valuing discretion and sound reasoning, they leverage first principles to guide critical decision-making processes that impact long-term outcomes.

Key Roles

  • •Coordinated capital allocation strategy under a major national framework, shaping multi-year investment priorities across biomedical R&D and medtech.
  • •Led end-to-end venture creation initiatives in biotech and advanced manufacturing, managing risk and capital efficiency for competitive funding.
  • •Synthesized scientific and market intelligence into clear business cases to inform senior leadership and policy decision-making.
  • •Developed structured programs for founder pipelines, enhancing market validation and investor communication, resulting in improved deal flow.
  • •Executed complex negotiations with senior stakeholders, balancing near-term ROI with long-term capability building.

Meet Me

Hi, I'm a passionate advocate for solving complex problems at the intersection of science and economics. With a strong background in capital allocation and risk management, I work collaboratively with diverse stakeholders to create impactful initiatives. I believe in the power of sound reasoning and disciplined decision-making to drive long-term value. Outside of my professional pursuits, I enjoy engaging with the community through science communication and mentoring the next generation of innovators.

Personas

Strategic Risk Advisor

  • •Expert in navigating complex decision-making landscapes, focusing on long-term value creation and risk management.
  • •Partnered with government bodies and organizations to align funding strategies with economic objectives.

Superpowers

Superpowers not available

Sweet Spot

This leader thrives at the intersection of scientific innovation and strategic capital management. Their unique ability to synthesize complex information into strategic insights allows them to guide organizations through uncertain landscapes while focusing on sustainable value creation.

Functional Skills

Capital Strategy
•
Investment Prioritization- Coordinated investment strategies to align with long-term economic and innovation goals.
•
Funding Negotiations- Led multi-stakeholder negotiations to secure long-term funding commitments.
•
Resource Allocation- Managed competitive funding allocations, ensuring capital efficiency and milestone achievement.
Venture Development
•
Venture Creation- Directed end-to-end initiatives in biotech and deep tech, from opportunity identification to execution.
•
Market Validation- Developed structured programs for founders to enhance business model design and communication with investors.
•
Technical Feasibility Assessment- Applied first-principles analysis for evaluating technologies and business ideas.
Stakeholder Management
•
Cross-Functional Collaboration- Facilitated partnerships across ministries and funding bodies to align strategies.
•
Communication of Complex Ideas- Translates technical complexities into actionable insights for senior leadership.
•
Negotiation Skills- Expertly manages negotiations with diverse stakeholders to achieve strategic objectives.

User Manual

This leader thrives in environments that value data-driven decision-making and strategic foresight. They prefer clear communication and collaborative frameworks that allow for deep engagement on complex topics. As a disciplined thinker, they value clarity in objectives and enjoy exploring innovative solutions that prioritize long-term outcomes.

Education

  • •Doctor of Philosophy (Ph.D.) in Human/Medical Genetics from a leading university in Singapore
  • •Bachelor's Degree in Biochemistry from a top-tier institution in the UK

Focus Areas

Capital AllocationRisk ManagementVenture CreationLong-Term Decision MakingStakeholder Engagement

Industries

BiotechnologyHealthcarePublic SectorResearch & Development

Geographical Coverage

SingaporeSoutheast Asia

Stage

Early StageGrowthInnovation

Personal Interests

Science CommunicationMentoringPolicy DevelopmentLong-Term Planning